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Diabetic nephropathy is currently the leading cause of end-stage renal disease worldwide, and occurs in approximately one third of all diabetic
patients. The molecular pathogenesis of diabetic nephropathy has not been fully characterized and novel mediators and drivers of the disease are
still being described. Previous data from our laboratory has identified the developmentally regulated gene Gremlin as a novel target implicated in
diabetic nephropathy in vitro and in vivo. We used bioinformatic analysis to examine whether Gremlin gene sequence and structure could be used
to identify other genes implicated in diabetic nephropathy. The Notch ligand Jagged1 and its downstream effector, hairy enhancer of split-1
(Hes1), were identified as genes with significant similarity to Gremlin in terms of promoter structure and predicted microRNA binding elements.
This led us to discover that transforming growth factor-beta (TGFβ1), a primary driver of cellular changes in the kidney during nephropathy,
increased Gremlin, Jagged1 and Hes1 expression in human kidney epithelial cells. Elevated levels of Gremlin, Jagged1 and Hes1 were also
detected in extracts from renal biopsies from diabetic nephropathy patients, but not in control living donors. In situ hybridization identified
specific upregulation and co-expression of Gremlin, Jagged1 and Hes1 in the same tubuli of kidneys from diabetic nephropathy patients, but not
controls. Finally, Notch pathway gene clustering showed that samples from diabetic nephropathy patients grouped together, distinct from both
control living donors and patients with minimal change disease. Together, these data suggest that Notch pathway gene expression is elevated in
diabetic nephropathy, co-incident with Gremlin, and may contribute to the pathogenesis of this disease.
© 2007 Elsevier B.V. All rights reserved.Keywords: Diabetic nephropathy; Gremlin; Notch; Jagged; Co-regulation; Promoter homology1. Introduction
Diabetic nephropathy (DN) is the primary cause of end-stage
renal disease worldwide [1]. Both type 1 and type 2 diabetic
patients develop nephropathy with an incidence of 25–40% [1].
The initial clinical indicator of DN is microalbuminuria, which
reflects functional and potentially reversible abnormalities
initiated by glomerular hyperfiltration. Microalbuminuria
predicts the development of overt proteinuria in both type 1⁎ Corresponding author.
E-mail address: finian.martin@ucd.ie (F. Martin).
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0925-4439/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2007.09.005and type 2 diabetes patients [2]. Both hyperglycemia and
glomerular hypertension are major drivers of DN progression,
with current therapies for DN including regulation of blood
glucose, angiotensin II receptor antagonists and angiotensin-
converting enzyme (ACE) inhibitors which slow, but do not
halt the progression to end-stage renal disease once overt
nephropathy is established [1]. An underlying genetic suscep-
tibility to DN is suggested by the observation that a cohort of
diabetic patients will develop DN despite rigorous hypergly-
cemic control.
The pathogenesis of DN is characterized by progressive loss
of renal function due to damage to the glomerulus (glomerulo-
sclerosis), and scarring of the kidney tubules due to relentless
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(tubulointerstitial fibrosis). Epithelial–mesenchymal transition
(EMT) is a process in which renal tubular cells lose their
epithelial phenotype and acquire characteristic features of me-
senchyme, compromising the function of both proximal and
distal tubules. There is some disagreement in the literature as
to the pathophysiological significance of EMT in diabetic ne-
phropathy in vivo. Those who support a role for EMT in renal
fibrosis in vivo suggest that up to 35% of disease-related fi-
broblasts originate from tubular epithelial cells, with in situ
fibroblast proliferation and infiltration of circulating fibroblasts
also contributing to this process [3,4]. EMT is therefore con-
sidered by some to be a phenotypic conversion fundamentally
linked to the pathogenesis of renal interstitial fibrosis [5]. Many
extrinsic drivers of EMT in the kidney have been identified,
including transforming growth factor-β (TGFβ1), epidermal
growth factor (EGF) and advanced glycation end-products
(AGEs) [6–8]. TGFβ1 signals through complexes of hetero-
trimeric transmembrane type I and type II receptors, activating
Smad2 or 3 to form complexes with Smad4 and trigger tran-
scriptional changes that drive EMT and fibrosis during dia-
betic nephropathy. Molecular interventions that act to reduce
TGFβ1 activity have been shown to be of benefit in renal
fibrosis in vivo [9–11]. Treatment of renal epithelial cells with
TGFβ1 in culture is sufficient to induce EMT, as characterized
by loss of E-cadherin expression and increased vimentin ex-
pression [12]. In contrast, proteins such as hepatocyte growth
factor (HGF) and bone morphogenetic factor-7 (BMP-7) have
been shown to counteract EMT induction by TGF-beta in vitro
and in vivo [13].
The majority of renal tubules in the adult kidney derive from
the metanephric mesenchyme via a process called mesenchy-
mal–epithelial transition (MET). Many genes that play a role in
embryogenesis and development have been implicated in
diabetic nephropathy. Prominent among these is Gremlin, a
member of the noggin/chordin like family of bone morphogenic
protein (BMP) antagonists [14]. In vitro, Gremlin expression is
elevated in kidney mesangial cells treated with high glucose and
TGFβ1 [15]. Mice lacking Gremlin die shortly after birth due to
renal agenesis [16]. Gremlin expression is low in normal, adult
kidney but is highly expressed in areas of tubular fibrosis in
kidneys from diabetic nephropathy patients [17]. Increased
Gremlin expression during nephropathy fits within the para-
digm of aberrant developmental gene expression during disease
progression.
We assessed the Gremlin proximal promoter for conserved
regulatory elements and identified members of the Notch
signalling pathway sharing common regulatory elements with
Gremlin. We also show that members of the Notch signalling
pathway are co-upregulated with Gremlin in an in vitro model
of TGFβ-induced EMT. Coordinated increases in Gremlin and
Notch family gene expression were also detected in kidney
biopsies from diabetic nephropathy patients, with co-localiza-
tion of Gremlin, Jagged1 and Hes1 detected predominantly in
the tubular compartments of kidneys from such patients. These
data therefore shed new light on the complex alterations in
kidney gene expression during diabetic nephropathy.2. Materials and methods
2.1. Transcription factor binding element analysis
Experimentally confirmed 5′ capped transcription start sites for human and
mouse Gremlin were determined from the Database of Transcription Start Sites
(DBTSS) (http://dbtss.hgc.jp/) [18] and the 1 kb proximal promoters for Gremlin
from both species was retrieved from their database. The proximal promoter for
rat Gremlin was retrieved from the UCSCGenomeBrowser (http://genome.ucsc.
edu/) [19] using the Refseq transcription start site. Initial analysis of Gremlin
promoter was performed using the sequence alignment programs ClustalW
(http://www.ebi.ac.uk/clustalw/) [20] and Pipmaker (http://pipmaker.bx.psu.edu/
pipmaker/) [21] to ascertain sequence conservation. In order to determine if the
apparent promoter conservation was due to a confounding influence, such as
extraneous open reading frames, the locus was analyzed using the UCSC
Genome Browser. Having established no confounding influence, the human,
mouse and rat 1 kb proximal promoters were analyzed for the presence of
transcription factor binding site consensus sequences using Matinspector (http://
www.genomatix.de) [22]. In order to reduce the number of false positives, results
were filtered for transcription factor sites appearing in all three species. Clusters
of significantly conserved transcription factor binding sites were chosen to search
for promoters with comparable sets of binding sites. Matrices corresponding to
the conserved transcription factor binding sites were retrieved from MatBase
(http://www.genomatix.de). Then a library of approximately 12,000 Unigene
accession 1 kb promoters was generated using HOMGL (http://homgl.biologie.
hu-berlin.de/homgl/) [23]. In order to determine which promoters in this library
contained clusters of these motifs, the promoter library was searched with
ClusterBuster (http://zlab.bu.edu/cluster-buster/) [24]. The promoters which
were identified were further filtered by gene ontology, using the tool eGON
(http://www.genetools.microarray.ntnu.no/egon/index.php) [25], to increase the
probability of finding co-regulated genes. This yielded a list of 10 genes, sharing
two gene ontology annotations with Gremlin andwhose 1 kb proximal promoters
contained clusters of transcription factor binding motifs in common with those
conserved in the Gremlin promoter.
2.2. 3′ UTR conserved motif analysis
We used a set of 106 conserved 3′UTR 8-mer motifs that were identified in a
genome-wide search [26]. Many of these conserved sites match known miRNA
binding sites. By parsing a table of the genes harbouring these putative miRNA
binding sites (Supplementary materials — [26]), we created a matrix of Refeq
Ids and the conserved motifs. To determine if the Gremlin 3′ UTR contained a
conserved motif and if any other genes shared such a motif, the matrix was
searched for sites matching the Gremlin 3′ UTR and cross-referenced for other
genes in whose 3′ UTR they appear. This process was carried out using R and
perl scripts.
2.3. CpG island motif analysis
There are two CpG islands in the Gremlin promoter. We decided to examine
if any other genes contained similar promoter CpG islands containing similar
motifs. Transcription factor binding motifs (1217 motifs) were obtained from
TRANSFAC 6.2 Professional [27], Jaspar [28] and from the collection of Xie
et al. [26]. Promoter sequences were taken from the 4-way conserved genome
sequence (human, mouse, rat and dog) as generated by Xie et al. [26]. The tffind
program from the Piptools package [29] was used to generate a frequency matrix
of the hits for each of the 1217 motifs in each of the 11,241 genes. The cpgplot
program from the EMBOSS package (http://emboss.sourceforge.net/apps/cvs/
cpgplot.html) was then used to detect CpG islands in the human promoter
sequences. We scanned the conserved regions of the CpG islands in the Gremlin
promoter and identified conserved motifs. We then identified similar conserved
motifs in the CpG islands of other genes.
2.4. Cell culture
Human kidney epithelial cells (HK-2) were purchased from the European
Collection of Cell Cultures (ECACC). HK-2 cells were cultured at 37 °C in a
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(Sigma) supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml
streptomycin, 10 ng/ml EGF, 36 ng/ml hydrocortisone, 4 pg/ml triiodothyronine
and 5 µg/ml insulin–transferrin–selenium (ITS) solution (Sigma). Cells were
subcultured using trypsin–EDTA at a ratio of 1:5.
2.5. Expression microarray analysis
Human kidney proximal tubular epithelial cells (HK-2) were plated in
triplicate for stimulation with TGFβ1 for 0, 24 or 48 h. This experiment was
carried out three times on different days, with triplicate samples for each time
point being pooled on each occasion, giving a total of 9 samples for Affymetrix
expression microarray analysis. Total RNAwas isolated using the Trizol method
and purified on Qiagen RNeasy columns. Total RNA (5 µg) was used to produce
biotinylated cRNA according to the manufacturer's instructions (Affymetrix,
HighWycombe, UK). Affymetrix test3 arrays were used to confirm the quality of
the labelled cRNA before hybridization to the Affymetrix HGU133A 2.0 arrays.
Raw data were imported into GeneSpring (version 5.0, Agilent Technologies)
normalized per chip to the 50th percentile and per gene to the median. A filtering
step was applied to select reliable data and also changing data (determined by
two-fold changes in normalized expression intensities between any two time
points). The entire data set, which is compliant to the MIAME criteria, is
described in Roxburgh et al. (in preparation), and will be deposited at Gene
Expression Omnibus upon publication. The data will be available at: http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?token1/4vlatfewwemyceh.
2.6. Real-time PCR analysis of HK-2 cells
Real-Time TaqMan PCRwas used to quantify relative gene expression levels
of Gremlin, Jagged1 and Hes1 from total RNA extracted from human kidney
proximal tubular epithelial (HK-2) cells. Pooled total RNA samples from the
Affymetrix DNA microarray experiment were used as templates for real-time
PCR validation. The PCR primers and TaqMan probe for Gremlin were: Forward
5′-GCAAAACCCAGCCGCTTAA-3′, reverse 5′-GGTTGATGATGGTGC-
GACTGT-3′, Taqman probe 5′-CAGACCATCCACGAGGAAGGCTGC-3′.
The primers and probe for E-cadherin, vimentin, Jagged1 and Hes1 were sup-
plied as a pre-optimised single tube primer/probe Gene Expression Assay (Ap-
plied Biosystems). The probes for the target genes were labelled with the
fluorescent dye, FAMon the 5′ end and a non-fluorescent quencher on the 3′ end.
18s rRNA was used as an endogenous control for normalization of the target
genes. 18s primers and probes were supplied as a pre-developed assay reagent
(PDAR,Applied Biosystems) labelled with VIC at the 5′ end and TAMRAon the
3′ end. PCR reactions were set up with Taqman Universal PCRMaster Mix from
Applied Biosystems. cDNAwas amplified on the 7900HT Sequence Detection
System (Applied Biosystems) at default thermal cycling conditions: 2 min at
50 °C, 10 min at 95 °C for enzyme activation and then 40 cycles of 15 s at 95 °C
for denaturation and 1 min at 60 °C for annealing and extension. Results were
analyzed using the relative standard curve method of analysis/ΔCt method of
analysis.
2.7. Clinical biochemistry
Serum creatinine and proteinuria were analyzed at each clinical center by
standard, local techniques. Glomerular filtration rate (GFR) was calculated using
the Cockroft-Gault formula.
2.8. Real-time PCR and expression microarray analysis of human
renal biopsies
Human renal biopsy specimens were collected in an international multi-
center study, the European Renal cDNA Bank-Kroener-Fresenius biopsy bank
(ERCB-KFB, see [30] for participating centers). Biopsies were obtained from
patients after informed consent and with the approval of the local human
research ethics committees.
Real-time PCR analyses of biopsies from patients with diabetic nephropathy,
minimal change disease (MCD) or control living donor (LD) tissue were
performed. Following renal biopsy, the tissue was transferred to RNase inhibitorand micro-dissected into glomerular and tubular fragments. Total RNA was
isolated from micro-dissected tubulointerstitial tissue (for details see [30]).
Reverse transcription and real-time PCRwere performed as reported earlier [30].
Pre-developed TaqMan reagents were used for human Gremlin, Jagged1 and
Hes1. Expression of target genes were normalized to three different house-
keepers (rRNA, GAPDH and cyclophilin) (Applied Biosystems) giving com-
parable results. The mRNA expression was analyzed by standard curve
quantification. Statistical analysis of the correlation of Gremlin, Jagged1 and
Hes1 was performed by normalization of the expression of each of the genes to
GAPDH, Cyclophilin and rRNA housekeepers separately. We performed
Pearson and Spearman analyses to determine if the expression of the three genes
correlated significantly. We also performed Mann–Whitney statistical analysis
to determine if the normalized expression of Gremlin, Jagged1 and Hes1
differed significantly between the diabetic group, compared to MCD or LD.
A set of samples from this collection was also analyzed by expression
microarray analysis (Affymetrix). A total of 24 kidney biopsies from individual
patients were included in this study: 3 pre-transplant kidney biopsies from living
donors (LD), 4 cadaveric donors (CD), 4 minimal change disease (MCD) and 13
progressive diabetic nephropathy patients (DN). The three groups (LD, CD and
MCD) were used as controls in the experiment (see Ref. [31]). The protocols for
Affymetrix microarray analysis and clinical data are given at http://diabetes.
diabetesjournals.org [32]. Subsequently, the expression of the genes of interest
(Notch pathway gene members) was visualized using the normalized RMAex-
press (http://rmaexpress.bmbolstad.com/) data and an Unsupervised Hierarchical
Cluster performed by dChip software [32].
2.9. In situ hybridization
Kidney samples were obtained by percutaneous renal biopsy from patients
undergoing diagnostic evaluation at the Division of Nephrology, Austral
University, Valdivia, Chile. The samples were studied after obtaining patient
consent and the project was approved by the local hospital ethics committee.
Renal biopsies from controls or diabetic nephropathy patients diagnosed before
specific treatment were studied. Control human kidney specimens (n=5) were
taken from unaffected kidney portions of tumour nephrectomies.
In situ hybridization (ISH) was performed as described previously for the TGFβ1
anti-sense probe (R&D Systems, Minneapolis, MN, USA [33]) and with the
following modifications for biotin-labelled human Gremlin (Invitrogen, Carlsbad,
CA, USA), Jagged1 and Hes1 (Sigma) probes. The Gremlin probe was: anti-sense
5′-CAGGCACTGACTCAGGAAGACA-3′, Jagged1 probe mix was: anti-sense
5′-CCTGACAGTATTATTGAAAAGGCT-3′ anti-sense 5′-GTACGGCTGG-
CAAGGCTTGTACTG-3′ and anti-sense 5′-CACGCCTGCCTCTCTGATC-
CCTGT-3′; Hes1 probe mix was 5′-CCTCTCTCCTTGGTCCTGGAACAG-3′
anti-sense 5′-CTGCGCTGAGCACAGACCCAAGTG-3′. For Gremlin, Jagged1
and Hes1 analysis, pre-treatment with endogenous biotin blocking system (Dako
Co, Carpinteria, CA, USA) was performed prior to proteinase K digestion. The
sections were incubated with a pre-hybridization solution (Dako, mRNA ISH
Solution) for 60 min at 37 °C followed by incubation with the anti-sense probe
overnight at 37 °C. The slides for Gremlin, Jagged1 and Hes1 were washed twice
with 2× SSC, 1× SSC and 0.5× SCC for 5 min at 37 °C. Detection was performed
with streptavidin–alkaline phosphatase conjugate (Dako) for 30 min at room
temperature, washed for 5 min with 1× TBS. NBT-BCIP enzyme substrate (R&D
Systems) was added for 60 min at 37 °C. Tissues were then dehydrated in ethanol
series andmounted in Canadian balsam (Polysciences Inc.,Warrington, PA, USA).3. Results
3.1. Promoter conservation exists between human Gremlin,
Jagged1 and Hes1
We initially performed an alignment of human, mouse and
rat Gremlin promoter regions. Experimentally confirmed pro-
ximal promoters for human and mouse Gremlin were retrieved
from the DBTSS (database of transcriptional start sites, http://
dbtss.hgc.jp/). The rat Gremlin proximal promoter was retrieved
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The Gremlin 5 kb proximal promoter for human, mouse and rat
was then aligned using MultiPipMaker (http://pipmaker.bx.psu.
edu/pipmaker/). Conservation was evident up to 2800 bp
upstream of the transcription start site and was highest in the
800 bp proximal to the transcription start site (Fig. 1A). Due to
the high level of conservation, the possibility of a confoundingFig. 1. Conservation of clusters of transcription factor binding sites in the Gremlin pro
(upper panel) and pip-plots (lower panel) for the 5 kb proximal promoters of hu
respectively. The human proximal promoter sequence is represented by the horizon
alignment as a diagonal line indicating position in both the human and mouse sequ
segments of alignment as a horizontal line, the left-to-right position of which is determ
percent identity of the mouse or rat sequence. In both comparisons regions of sequen
exception of an apparent deletion in the mouse genome corresponding to −700 to −12
Matinspector analysis of human, mouse and rat Gremlin 1 kb proximal promoters (−
shown. Each coloured tab represents an individual binding site identified by Matinsp
ClusterBuster score output for genes identified as having clusters of the transcription
whose score was higher than the 7.0 cutoff and also shared gene ontology with Grem
the cluster within the promoter region, and to the right a graphical representation of t
matrix sites, and the colours correspond to the matrices above.influence such as the presence of another open reading frame
was investigated using the UCSC Genome Browser. No con-
founding influence was found, suggesting that the conserved
region was that of the functional Gremlin promoter. To analyze
the potential transcription factors responsible for Gremlin
regulation, Matinspector (http://www.genomatix.de/) was used
to search for conserved transcription factor binding sites. Withinximal promoter and their occurrence in other promoters. (A) Combined dot-plots
man Gremlin versus mouse Gremlin and human Gremlin versus rat Gremlin
tal axis in all cases. The dot-plots represent each of the gap-free segments of
ences and the human and rat sequences. The pip-plots depict each one of these
ined by the human coordinates and the vertical placement of which indicates the
ce identity extend up to 2.8 kb upstream of the transcription start site. With the
00 bp in human, the sections of gap-free alignments are almost uninterrupted. (B)
1 to −400 bp shown). Transcription factor matrices common to all 3 species are
ector, [sites are identified in the legend to its right]. The lower panel shows the
factors found conserved in the Gremlin promoter. Shown here are those genes
lin. Highlighted is the Jagged1 result, indicating its score of 8.27, the position of
he cluster. Once again the coloured tabs represent individual transcription factor
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two blocks of transcription factor binding sites were detected,
from −50 to −600 bp and from −600 to −900 bp (Fig. 1B).Fig. 2. Gremlin shares regulatory elements with Jagged1 and Hes1 (A) Using cons
binding sites in the Gremlin 3′UTR. Further analysis revealed 23 genes (Table 2, Supp
the Notch ligand Jagged1 shared a TGTGAATA motif in its 3′ UTR with Gremlin.
islands we found 6 conserved motifs 5 of which are NFKappa B related, including
pathway members sharing a similar motif in its CpG island with Gremlin. We also
contains a MA0105 motif.From −50 to −600 bp, transcription factor binding sites were
highly conserved in all 3 species. In the −600 to −900 bp
region, some conservation was still apparent, but the order anderved 3′ untranslated (UTR) motif data [26], we identified 5 potential miRNA
lemental data [26]) that shared one or more of these miRNA target sites. Of these
(B) The Gremlin proximal promoter contains two CpG islands. Within those 2
MA0105 (Jaspar accession) p50 subunit of NFKappaB. We searched for Notch
found that Hes1 contains a CpG island in its proximal promoter, and similarly
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−600 bp region. Twenty three conserved transcription factor
binding sites were chosen from the −50 to −600 bp region to
search the promoter library for the presence of clusters of such
binding elements in other promoters (see Table 1, Supplemental
data [26]). The transcription factor binding sites were chosen
due to known TGFβ regulation or strong involvement in
embryogenesis (e.g. Smad, Pax, GATA). ClusterBuster analysis
(see Materials and methods) revealed that genes previously
shown to be co-regulated with Gremlin in diabetic nephropathy
such as Profilin 1 (13.7) and CTGF/Cyr61 (12.5) [34] were
among the highest scoring promoters detected (Fig. 1B). Grem-
lin (10.4) itself also scored highly in the analysis. When gene
ontology information was added to the resulting list, 10 genes
shared two ontological traits (extracellular secreted protein and
morphogenesis) with Gremlin. Of those, apart from the Gremlin
and CTGF/Cyr61, Inhibin-A and Jagged1 scored most highly
in the ClusterBuster analysis. These data suggest that signifi-
cant homology and similarity exists between the promoters of
Gremlin, CTGF/Cyr61 and Jagged1.
To provide further evidence for potential co-regulation of
Gremlin and genes such as Jagged1, we scanned the identified
gene sequences for predicted microRNA (miRNA) binding
sites. miRNA analysis using 3′ UTR conserved sequences in
[26] indicated that Gremlin had 5 putative miRNA binding sites
in its 3′ UTR. Twenty three genes in the database shared one or
more of these sites. Using HOMGL (http://homgl.biologie.Fig. 3. TGFβ1 induces gene expression-like changes in human kidney epithelial cel
were treated for 0, 24 or 48 h with 10 ng/ml TGFβ1. Total RNAwas extracted and
described. (A) Specific TaqMan probes for E-cadherin and vimentin were used to amp
levels for each gene. Mean fold change in expression for each experiment (in tripli
represent standard error of the mean (SEM). Statistical significance was calculated
(B) Total RNAwas analyzed on HG U133A 2.0 Affymetrix chips as described in Ma
and CTGF at 24 and 48 h compared to control are indicated.hu-berlin.de/homgl/), we then compared the ClusterBuster gene
list with the miRNA gene list and found that 4 genes appeared
on both lists. These included Gremlin itself, and one other gene
which also shared ontological traits with Gremlin—the Notch
ligand Jagged1 (Fig. 2A).
Finally, we identified TFBS motifs in CpG islands in
Gremlin spanning the transcription start site (tss) and in the
region proximal to the coding sequence, that were conserved in
human, mouse, rat and dog. A comparison of these genes
containing CpG islands revealed that both Gremlin and Hes1
have a conserved NFкB motif in CpG islands near their pro-
moters (Fig. 2B), suggesting the possibility of co-regulation of
Notch pathway expressing genes with Gremlin.
Based on the conservation of promoter sequences between
Gremlin and Jagged1, together with common predicted micro-
RNA sites and conserved promoter motifs in Hes1, these data
suggest that genes expressing Notch signalling pathway com-
ponents may be co-regulated with Gremlin. It was therefore of
interest to observe if this potential co-regulated expression was
associated with renal fibrosis and the pathogenesis of diabetic
nephropathy.
3.2. TGFβ1 stimulates Gremlin, Jagged1 and Hes1 gene
expression in renal tubular epithelial cells
TGFβ1 is a major driver of epithelial–mesenchymal tran-
sition (EMT) and renal fibrosis both in vitro and in vivo [35,36].ls consistent with EMT. Human proximal tubule kidney epithelial cells (HK-2)
processed for quantitative TaqMan PCR and Affymetrix microarray analysis as
lify individual RNA transcripts. Fluorescence intensities were normalized to 18s
cate) were calculated and plotted versus TGFβ1 exposure time (h). Error bars
using two-tailed t-tests. ⁎pb0.02, ⁎⁎pb0.05, ⁎⁎⁎pb0.0001, ⁎⁎⁎⁎pb0.00005.
terials and methods. Fold change in expression of fibronectin, collagen, Gremlin
Fig. 4. TGFβ1 induces Gremlin, Jagged1 and Hes1 expression in human kidney epithelial cells in culture. Human proximal tubule kidney epithelial cells (HK-2) were
treated for 0, 24 or 48 h with 10 ng/ml TGFβ1. Total RNAwas extracted and processed for Affymetrix microarray analysis as described in Materials and Methods.
(A) Changes in gene expression were determined using Affymetrix GeneSpring® analysis software. Each time point is the average of three independent experiments
carried out on separate days. Fold change in expression of Gremlin, Jagged1 and Hes1 are plotted versus duration of TGFβ1 treatment (h). (B) Quantitative TaqMan
PCRwas carried out on the total RNA samples used in the Affymetrix experiment above. Specific TaqMan probes for Gremlin, Jagged1 and Hes1 were used to amplify
individual RNA transcripts. Fluorescence intensities were normalized to 18s RNA levels for each gene. Mean fold change in expression for each experiment (in
triplicate) were calculated and plotted versus duration of TGFβ1 treatment (h). Error bars represent standard error of the mean (SEM). Statistical significance was
calculated using two-tailed t-tests. ⁎pb0.01, ⁎⁎pb0.05, ⁎⁎⁎pb0.005, ⁎⁎⁎⁎pb0.00005, ⁎⁎⁎⁎⁎pb0.000001.
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HK-2 tubular epithelial cells were treated with TGFβ1 for various
times to stimulate EMT-like cellular changes. Induction of EMT
was validated by decreased E-cadherin expression (epithelial
cell marker) and increased vimentin expression (mesenchymal
cell marker, Fig. 3A). RNA was then probed on human HG
U133A 2.0 Affymetrix gene arrays, and changes in expression
assessed using GeneSpring software. Using a signal–log ratio
of 1.5 (representing a 2-fold change in gene expression), expres-
sion of 109 genes was upregulated in response to TGFβ1,
whereas 97 genes were downregulated in the same experiment
(Roxburgh et al., in preparation). Several genes whose altered
expression had previously been identified by our group and others
in models of EMT were identified, including fibronectin, type I
collagen alpha 1, type IV collagen alpha 1 and connective tissue
growth factor (CTGF) suggesting that these epithelial cells had
indeed undergone EMT-like changes (Fig. 3B).
Interestingly, the most highly upregulated gene in response
to TGFβ1 at both 24 h and 48 h time points was Jagged1, with a
17-fold upregulation at 24 h and an 18-fold upregulation at 48 h
detected (Fig. 4). Increased expression of hairy enhancer of split
(Hes1) was also detected in the microarray experiment, with 3-
fold increases at 24 h and 48 h detected (Fig. 4). As previously
demonstrated, TGFβ1 increased Gremlin expression in kidney
epithelial cells (3-fold at 24 h and 4-fold at 48 h, Fig. 4).
To verify these data, real-time TaqMan PCR was performedusing oligonucleotides specific for Gremlin, Jagged1 and Hes1.
Increases in expression in all three genes at both time points
were observed using TaqMan PCR, and the fold change in
expression was similar to that observed by microarray ex-
pression analysis (Fig. 4, lower panels). These data suggest that
TGFβ1, a major pro-fibrotic cytokine, increased the expression
of Jagged1 and Hes1, together with Gremlin, in human kidney
epithelial cells in vitro.
3.3. Expression of Gremlin, Jagged1 and Hes1 is elevated in
biopsies from diabetic nephropathy patients
To examine whether increased expression of Notch signalling
pathway genes was a feature of human diabetic nephropathy,
samples from human patients were analyzed. The clinical pro-
file of our patient cohort of living donor (LD) cadaveric donor
(CD), minimal changes disease (MCD) and diabetes showed
significantly reduced glomerular filtration rates (GFR) in dia-
betic patients versus controls (Diabetes, 36.6 ml/min+/−14.7,
minimal change disease (MCD) 102.25 ml/min+/−24.99,
pb0.05), suggesting stages III to IV chronic kidney disease
(CKD). Renal biopsy cores from these patient cohorts were
micro-dissected, and RNA was extracted from the isolated
tubulointerstitial segments. Tubulointerstitial RNA from diabetic
patients, transplant donor controls and minimal change disease
controls were analyzed for the expression of Jagged1, Hes1
Fig. 5. Increased expression of Gremlin, Jagged1 and Hes1 mRNAwas detected in biopsies from diabetic nephropathy patients, by RT-PCR. Real-time Taqman PCR
was performed on RNA extracted from renal biopsies from control living donor (LD, n=10), minimal change disease (MCD, n=5) or diabetic nephropathy (diabetes,
n=18) as described in Materials and methods. Shown is the expression level in arbitrary units for Gremlin, Jagged1 and Hes1 normalized to the housekeeper GAPDH.
Using Mann–Whitney non-parametric tests we found that the diabetic group shows significantly higher expression of Gremlin ( p=0.006), Jagged1 ( p=0.001) and
Hes1 ( p=0.011) compared to LD andMCD. This was true for all housekeeping genes used. Both latter groups do not show a significant difference in expression levels.
Using Pearson (numeric) and Spearman (rank) tests we analyzed the expression levels of the 3 genes for statistical correlation, normalized to each housekeeper
separately. The expression levels of the 3 genes were found to correlate significantly. This was true for each housekeeper and for both statistical tests. In the Pearson/
Parametric tests Gremlin and Jagged1 had correlation coefficients of 0.627 (rRNA), 1.000 (GAPDH) and 0.756 (Cyclo), in the non-parametric/Spearman-Rho tests the
coefficients were 0.530 (rRNA), 0.876 (GAPDH) and 0.674 (Cyclo). For Gremlin and Hes1 the Pearson coefficients were found to be 0.519 (rRNA), 0.999 (GAPDH) and
0.544 (Cyclo), the Spearman-Rho coefficients were 0.346 (rRNA) (0.05 level significance), 0.809 (GAPDH) and 0.527 (Cyclo). In all cases, unless specified, p≤0.01.
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Whitney-Test to analyze differences, the cohort of diabetic
nephropathy patients exhibited a significantly higher expressionFig. 6. Gremlin, Jagged1 and Hes1 expression co-localizes to tubular epithelial cells
from control (upper panel) and diabetic nephropathy (lower panel) patients were p
stained for Gremlin (left panel), Jagged1 (middle panel) or Hes1 mRNA (right paneof Gremlin, Hes1 and Jagged1 compared to control patients (LD)
and minimal changes disease (MCD, Fig. 5). Furthermore, the
expression of all three genes in the renal tubulointerstitiumin serial kidney sections of DN patients. In situ hybridization of renal biopsies
erformed as described in Materials and methods. Serial sections of 4 μm were
l). Glomeruli (⁎) and tubules (arrows) are indicated.
Fig. 7. Key genes of the Notch signalling pathway are upregulated in diabetic nephropathy. Hierarchical cluster analysis of gene expression profiles from DN renal
biopsies and different ‘controls’. Tubulointerstitial compartments of renal biopsies from patients with DN and MCD, as well as pre-transplant biopsies from related LD
and CD kidneys, were analyzed. Gene expression profiles were determined using Affymetrix oligonucleotide arrays HG-U133A. Transcript abundance is displayed on
a red–green colour scale, with red expression above and green below the median. The cluster dendrogram sorts the patients with the most similar gene expression
profiles together with the shortest branches. Hierarchical clustering showed a clear distinction between the DN patients and the LD/MCD/CD patients, with CD4 being
the one exception, clustering within the DN group. The above cluster shows non-redundant genes expressed higher than the cutoff (expression value=5.83) that are
significantly differentially regulated ( pb0.05). Included in this cluster are genes that function at key points in the Notch pathway: ligand (Jagged1), receptor (Notch2
and Notch3), receptor cleavage (ADAM10), transcriptional activators (RBPSUH, SKIP), notch ligand activators (MIB1), notch repressor (NLE1) as well as other
genes shown to interfere with Notch signalling (APP, MECT1).
18 D.W. Walsh et al. / Biochimica et Biophysica Acta 1782 (2008) 10–21correlated with each other when normalized to any of the 3
housekeeping genes separately (see legend of Fig. 5). These data
suggest that Jagged1 andHes1 gene expression is upregulated in a
coordinated fashion in the tubulointerstitial of kidneys from
diabetic nephropathy patients with that of Gremlin.
3.4. Increased expression of Jagged1 and Hes1 and Gremlin is
detected in the tubular compartment of renal biopsies from
diabetic nephropathy patients
To identify the specific region of the nephron where
Gremlin, Jagged1 and Hes1 levels were upregulated in diabetic
nephropathy, their expression was studied by in situ hybridiza-
tion (Fig. 6). No expression of Gremlin, Jagged1 or Hes1 was
observed in normal human kidney (Fig. 6, upper panels). In
contrast, abundant Gremlin, Jagged1 and Hes1 mRNA expres-
sion was co-expressed in tubular epithelial cells in serial
sections of kidney biopsies from patients with diabetic nephro-
pathy (Fig. 6, lower panels). Expression of all three genes
appears to localize to the same tubular structures, based on
staining of serial sections. These data suggest that upregulation
of Gremlin, Jagged1 and Hes1 occurs in the tubuloepithelium
during the progression of diabetic nephropathy.
3.5. Notch signalling pathway genes are upregulated in
biopsies from diabetic nephropathy patients
To broaden our analysis, expression microarray data of
tubulointerstitium from patients with established diabetic
nephropathy (DN) versus either living donor pre-transplant
biopsies (LD) alone or including minimal change disease
(MCD) or cadaveric donor (CD) as controls were analyzed for
the expression levels of all detectable members of the Notchsignalling pathway. The clinical profile of these patients was
previously published by Schmid and colleagues [31]. Using a
cutoff expression value of 5.83 and a p-valueb0.05, ten Notch
pathway related genes were found to be significantly differen-
tially expressed in DN versus LD and MCD. Included among
these were the Notch ligand Jagged1, two Notch receptors
Notch2 and Notch3 and SKI-Interacting Protein (SKIP, Fig. 7).
Of these genes, MECT1 and Notch3 were found to be sig-
nificantly downregulated in the DN group, while genes such as
Jagged1, Notch2 and ADAM10 are all upregulated (Fig. 7).
Thus, the expression levels of multiple genes in the Notch signal
transduction pathway are altered in diabetic nephropathy.
4. Discussion
The data presented in this report explore the parallel po-
tentially coordinated upregulation of Gremlin and Notch family
genes in the kidneys of diabetic nephropathy patients. Using a
bioinformatics approach, common clusters of transcription fac-
tor binding and regulatory elements in the promoters of Gremlin
and Jagged1 (the Notch ligand) were identified. TGFβ1, the
primary pro-fibrotic cytokine involved in renal fibrosis, in-
creased the expression of Gremlin, Jagged1 and Hes1 (a down-
stream target of the Notch signalling pathway) within the same
time-frame in tubular epithelial cells. Elevations in all three
genes were observed in cDNA samples isolated from kidney
biopsies from diabetic nephropathy patients, but not controls. In
situ hybridization identified the kidney tubules as the main site
of Gremlin, Jagged1 and Hes1 upregulation during DN. Finally,
changes in expression of other members of the Notch signalling
pathway were also detected in renal biopsies from DN patients,
suggesting that upregulation of Notch pathway signalling is a
feature of diabetic nephropathy.
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human, mouse and rat revealed an unusually high degree of
conservation up to −2800 bp upstream of the predicted tran-
scription start site, with particularly strong alignment in the first
800 bp (Fig. 1A). Recent studies suggest that the average
sequence identity between orthologous human and mouse
promoter regions peaks at approximately 70% at the TSS
[37,38] and falls rapidly with distance from the TSS. The
comparatively high degree of conservation evident in ortholo-
gous Gremlin human, mouse and rat promoters suggested that
common sequence elements exist and are functionally relevant
in the promoters of Gremlin in all three species.
Consistent with the high degree of conservation in the
Gremlin promoter, clusters of transcription factor binding sites
common to human, rat and mouse were identified, many of
which had previously been implicated in TGFβ signalling and
embryogenesis (Fig. 1B). These included Smad3 [39], Fast1
[40] and Mitf [41].
These conserved transcription factor binding elements were
then used to identify other genes with common promoter re-
gulatory elements. This approach identified the previously im-
plicated TGFβ1 co-regulated gene CTGF, as well as Gremlin
itself (Fig. 1B). Also present in this group was Jagged1, the
ligand for the Notch receptor which regulates multiple devel-
opmental processes [42]. Mutations in Jagged1 can lead to the
genetic disorder Alagille syndrome [43], which results in multi-
organ defects, including, but not limited to cardiac, ocular and
facial [44]. A similar approach was taken by Kielbasa et al. [45],
who described a method for predicting muscle-specific gene
targets for a set of transcription factors also using a strategy
centered on analysis within ClusterBuster.
The presence of common motifs in CpG islands in Gremlin
and Hes1 (a downstream target of Jagged1/Notch signalling)
genes, as well as microRNA binding sites in the 3′ UTR of
Gremlin and Jagged1 genes further support our suggestions that
common regulatory strategies exist for expression of Gremlin
and genes of the Notch signalling pathway. Both Gremlin and
Jagged1 control developmental processes in many species
[16,46–48]. Gremlin is a BMP antagonist whose temporal and
spatial expression is crucial to normal development [16]. Mice
lacking Gremlin exhibit limb deformities in both fore and hind-
limb [16]. Of relevance to our study, mice lacking Gremlin
die shortly after birth due to renal agenesis [16], suggesting
an important role for Gremlin in kidney development. Jag-
ged1 mutations cause Alagille syndrome in humans, an auto-
somal dominant condition affecting the liver, kidneys, heart and
craniofacial structures [49]. To date, common mechanisms of
regulation for Gremlin and Jagged1 have not been described,
although coordinated expression of both genes may be re-
quired for correct sonic hedgehog signalling during epithelial–
mesenchymal signalling in mouse limb bud development [50].
TGFβ1 is a key pathogenic driver of renal fibrosis in diabetic
nephropathy and other forms of kidney disease [51]. TGFβ1
stimulates increases in expression of genes such as fibronectin,
CTGF and Gremlin in models of glucose-induced damage in
kidney cells [15]. Cells treated with TGFβ1 underwent EMT-
like changes, as confirmed by decreased E-cadherin levels andincreased vimentin expression (Fig. 3A). Treatment of renal
epithelial cells with TGFβ1 is known to induce EMT in epi-
thelial cells [13]. Several genes that are also characteristic of
TGFβ1-induced fibrosis were also increased, including fibro-
nectin, collagen and CTGF (Fig. 3B). TGFβ1 increased the
expression of Gremlin, as well as Jagged1 and Hes1 in human
proximal epithelial cells (HK-2) in a cell culture model of
epithelial–mesenchymal transition (EMT, Fig. 4). In agreement
with our identification of common regulatory elements within
the Gremlin and Jagged1 promoters, our data suggested that
signal transduction cascades triggered by TGFβ1 activated the
expression of Gremlin and Jagged1, as well as Hes1 in tubular
epithelial cells. Morrissey et al. have also observed TGFβ1-
mediated Jagged1 upregulation in human kidney cells [52].
These authors also identified the kidney tubules as the primary
site of Jagged1 upregulation in a mouse model of acute renal
fibrosis [52]. Other data suggest that TGFβ-induced EMT in
human keratinocytes is associated with the expression of the
hairy enhancer of split-like genes in the Notch signalling path-
way [12]. Functional inactivation of the Notch ligand Jagged1
or Notch has also been shown to inhibit TGFβ1-induced EMT
[53]. Notch signalling induced by TGFβ has been shown to
occur in a biphasic manner [53]. At the onset of EMTa subset of
Notch target genes, together with its ligand Jagged1 are induced
by TGFβ1, Smad3-dependent, and Notch independent. After
prolonged TGFβ1 exposure, a second, sustained wave of Notch
signalling occurs through TGFβ-induced synthesis of Jagged1,
Notch dependent [53]. Together, these data suggest that
TGFβ1-mediated increases in Notch signalling may act to sus-
tain or amplify its pro-fibrotic effects in kidney cells.
Based on bioinformatic and in vitro data, we hypothesized
that coordinated upregulation of Gremlin with members of the
Notch signalling pathway such as Jagged1 and Hes1 is a feature
of renal fibrosis. Our diabetic patient cohort displayed a sig-
nificantly decreased GFR resulting fromDN. The scatter in GFR
observed in the diabetic patient group is indicative of a
heterogeneity in renal function, with values in these patients
ranging from 60 ml/min down to 6 ml/min. Thus, the majority of
these patients can be classified as either moderate or severe CKD
as a result of DN. Levels of all three gene transcripts of interest
were elevated in biopsies from diabetic nephropathy patients
compared to normal living donor or minimal change disease
controls (Fig. 5). Further analysis revealed that the upregulation
of all three genes correlated with each other in a statistically
significant manner, when compared to any of three housekeep-
ing genes. Our correlation analysis highlights that Gremlin,
Jagged1 and Hes1 follow a shared pattern of upregulation in the
kidney tubules during diabetic nephropathy. Supporting this
conclusion, we observed significant staining of Gremlin,
Jagged1 and Hes1 in the same kidney tubules in diabetic
nephropathy, but not in control sections (Fig. 6).Weaker staining
for all three genes was observed in glomeruli. Previous reports
have identifiedGremlin upregulation in the tubular compartment
of diabetic nephropathy kidneys [17]. Gremlin mRNA levels
correlated well with renal dysfunction in these patients [17].
Similar to Dolan et al. (2005), Gremlin upregulation was
predominantly detected in the tubulointerstitium, with lower
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Gremlin, and indeed Notch family signalling may play a more
significant role in tubulointerstitial fibrosis than in glomerulo-
sclerosis during DN. To our knowledge, our data is the first to
report increased expression of Notch family genes such as
Jagged1 and Hes1 in the kidneys of diabetic nephropathy
patients. Furthermore, the strong correlation between Gremlin
and Jagged1/Hes1 expression suggests that drivers of renal
fibrosis such as TGFβ1 may be triggering coordinated waves of
such gene expression that contribute to the pathogenesis of renal
disease. Based on the tight co-regulation of Gremlin with two
genes of the Notch signalling pathway (Jagged1 and Hes1), we
then identified other genes in the Notch pathway whose expres-
sion was also elevated in kidney biopsies from DN patients
compared to controls (Fig. 7). Genes encoding the Notch re-
ceptors, ADAM-10 (a metalloproteinase essential for Notch
signalling [54]) and Ski-interacting protein (SKIP, a co-activator
of transcription that binds to the activated intracellular portion of
the Notch receptor [55]) were all highly expressed in biopsies
from human DN patients compared to controls (Fig. 7). These
data fit within the paradigm of the re-emergence of developmen-
tal gene expression in the context of diabetic nephropathy, where
developmental gene expression may be part of an inappropriate
repair mechanism to reverse the progression of renal fibrosis.
Our data describe a novel link between Gremlin upregulation
and increased Notch pathway signalling downstream of TGFβ1
in diabetic nephropathy. Further experiments are required to
determine whether increased Notch signalling acts to amplify or
prolong TGFβ1 signalling in the diabetic kidney and what is the
precise role of Gremlin in this paradigm. Elucidation of these
cellular mechanisms will allow potentially novel interventions
that aim to delay or prevent the onset of renal fibrosis in diabetic
nephropathy.
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